Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis: Influenza”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01086657
What this trial is testing

An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...

Who this might be right for
Influenza A Virus, H5N1 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 64
Not applicableStudy completedNCT01100294
What this trial is testing

Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 10
Not applicableStudy completedNCT03331991
What this trial is testing

Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel

Who this might be right for
Respiratory Tract DiseaseInfluenza
Abt Associates 2,400
Large-scale testing (Phase 3)Not Yet RecruitingNCT06800950
What this trial is testing

Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Who this might be right for
Influenza, HumanInfluenza, Human PreventionInfluenza a+2 more
Institute of Medical Biology, Chinese Academy of Medical Sciences 4,400
Not applicableStudy completedNCT02266277
What this trial is testing

System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts

Who this might be right for
InfluenzaInfections, Pneumococcal
University of Massachusetts, Worcester 30,000
Post-approval studies (Phase 4)Study completedNCT01728090
What this trial is testing

Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections

Who this might be right for
Upper Respiratory InfectionsInfluenzaCommon Cold
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental 1,640
Large-scale testing (Phase 3)Study completedNCT01761435
What this trial is testing

Clinical Trial Evaluating Efficacy and Safety of One Dose Versus Two Doses of Influenza Vaccination

Who this might be right for
Infection in Solid Organ Transplant Recipients
Fundación Pública Andaluza Progreso y Salud 499
Large-scale testing (Phase 3)Study completedNCT01382329
What this trial is testing

H5N1 Vaccine Study in Japanese Adults

Who this might be right for
H5N1 Influenza
Alachua Government Services, Inc. 340
Testing effectiveness (Phase 2)Study completedNCT00895947
What this trial is testing

Interferon Alpha Lozenges in the Prevention of Winter Colds and Flu

Who this might be right for
Upper Respiratory Tract Infections
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. 200
Post-approval studies (Phase 4)Study completedNCT00677820
What this trial is testing

A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine

Who this might be right for
Influenza
MedImmune LLC 300
Large-scale testing (Phase 3)Looking for participantsNCT06574503
What this trial is testing

Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against Influenza

Who this might be right for
Influenza
Jiangxi Qingfeng Pharmaceutical Co. Ltd. 748
Testing effectiveness (Phase 2)WithdrawnNCT02713061
What this trial is testing

A Subcutaneous Injection of TAK-850 in Healthy Adult Participants

Who this might be right for
Influenza Prevention
Takeda
Testing effectiveness (Phase 2)Study completedNCT00537524
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years

Who this might be right for
Prophylaxis of Avian Influenza
Novartis Vaccines 471
Large-scale testing (Phase 3)Study completedNCT01961960
What this trial is testing

Evaluate Intramuscular ASP7374

Who this might be right for
InfluenzaVaccine
UMN Pharma Inc. 55
Not applicableLooking for participantsNCT07314593
What this trial is testing

Omega-Cold Supplementation With Free Fatty Acids for the Prevention of Respiratory Infections in Adults.

Who this might be right for
Respiratory Infections
Landspitali University Hospital 400
Early research (Phase 1)Study completedNCT00646152
What this trial is testing

Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study

Who this might be right for
InfluenzaSevere Acute Respiratory Distress SyndromeSmallpox+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 57
Early research (Phase 1)Study completedNCT00309647
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 400
Large-scale testing (Phase 3)Active Not RecruitingNCT07159763
What this trial is testing

Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

Who this might be right for
Influenza
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 10,000
Testing effectiveness (Phase 2)Study completedNCT06890429
What this trial is testing

Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Who this might be right for
Respiratory Synctial Virus Infections
Research Institute of Influenza, Russia 120
Not applicableStudy completedNCT01390792
What this trial is testing

Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)

Who this might be right for
Influenza, Human
GlaxoSmithKline 622
Next Page